As Congress considers lowering drug costs, pharma CEOs target key senators with campaign cash

WASHINGTON — Top pharmaceutical CEOs have targeted a small group of Republican senators with roughly $200,000 in campaign donations in the past year, according to a STAT review of campaign finance disclosures.